All diagrams in medicine handling and targets
Medication target overlays
Three medicines, different target actions: a simplified comparison. A target diagram is not a medicine ranking or a personal treatment choice.
Medication target overlays
Scoped educational mechanism
Open larger diagram · Full-size PNG · Diagram page
Read the diagram explanation and sources
Methylphenidate and atomoxetine principally inhibit reuptake through different target profiles. Dexamfetamine has substrate/releasing actions and additional intracellular effects demonstrated in experimental models. These distinctions do not exhaust the pharmacology or settle how a medicine improves ADHD symptoms. Evidence from cell or animal preparations cannot be read directly as a therapeutic concentration, personal response prediction or dose equivalence. Current product-specific information is linked; an individual prescribing decision remains separate.
What the diagram shows
Methylphenidate and atomoxetine principally inhibit reuptake through different target profiles. Dexamfetamine has substrate/releasing actions and additional intracellular effects demonstrated in experimental models. These distinctions do not exhaust the pharmacology or settle how a medicine improves ADHD symptoms. Evidence from cell or animal preparations cannot be read directly as a therapeutic concentration, personal response prediction or dose equivalence. Current product-specific information is linked; an individual prescribing decision remains separate.